Cargando…

Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles

We previously reported that siRNA delivery to the brain is improved by the nose-to-brain delivery route and by conjugation with polyethylene glycol-polycaprolactone (PEG-PCL) polymer micelles and the cell-penetrating peptide, Tat (PEG-PCL-Tat). In this study, we evaluated the nose-to-brain delivery...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanazawa, Takanori, Kurano, Takumi, Ibaraki, Hisako, Takashima, Yuuki, Suzuki, Toyofumi, Seta, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781507/
https://www.ncbi.nlm.nih.gov/pubmed/31540164
http://dx.doi.org/10.3390/pharmaceutics11090478
_version_ 1783457388772196352
author Kanazawa, Takanori
Kurano, Takumi
Ibaraki, Hisako
Takashima, Yuuki
Suzuki, Toyofumi
Seta, Yasuo
author_facet Kanazawa, Takanori
Kurano, Takumi
Ibaraki, Hisako
Takashima, Yuuki
Suzuki, Toyofumi
Seta, Yasuo
author_sort Kanazawa, Takanori
collection PubMed
description We previously reported that siRNA delivery to the brain is improved by the nose-to-brain delivery route and by conjugation with polyethylene glycol-polycaprolactone (PEG-PCL) polymer micelles and the cell-penetrating peptide, Tat (PEG-PCL-Tat). In this study, we evaluated the nose-to-brain delivery of siRNA targeting TNF-α (siTNF-α) conjugated with PEG-PCL-Tat to investigate its therapeutic effects on a transient middle cerebral artery occlusion (t-MCAO) rat model of cerebral ischemia-reperfusion injury. Intranasal treatment was provided 30 min after infarction induced via suturing. Two hours after infarction induction, the suture was removed, and blood flow was released. At 22 h post-reperfusion, we assessed the infarcted area, TNF-α production, and neurological score to determine the therapeutic effects. The infarcted area was observed over a wide range in the untreated group, whereas shrinkage of the infarcted area was observed in rats subjected to intranasal administration of siTNF-α with PEG-PCL-Tat micelles. Moreover, TNF-α production and neurological score in rats treated by intranasal administration of siTNF-α with PEG-PCL-Tat micelles were significantly lower than those in untreated and naked siTNF-α-treated rats. These results indicate that nose-to-brain delivery of siTNF-α conjugated with PEG-PCL-Tat micelles alleviated the symptoms of cerebral ischemia-reperfusion injury.
format Online
Article
Text
id pubmed-6781507
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67815072019-10-30 Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles Kanazawa, Takanori Kurano, Takumi Ibaraki, Hisako Takashima, Yuuki Suzuki, Toyofumi Seta, Yasuo Pharmaceutics Article We previously reported that siRNA delivery to the brain is improved by the nose-to-brain delivery route and by conjugation with polyethylene glycol-polycaprolactone (PEG-PCL) polymer micelles and the cell-penetrating peptide, Tat (PEG-PCL-Tat). In this study, we evaluated the nose-to-brain delivery of siRNA targeting TNF-α (siTNF-α) conjugated with PEG-PCL-Tat to investigate its therapeutic effects on a transient middle cerebral artery occlusion (t-MCAO) rat model of cerebral ischemia-reperfusion injury. Intranasal treatment was provided 30 min after infarction induced via suturing. Two hours after infarction induction, the suture was removed, and blood flow was released. At 22 h post-reperfusion, we assessed the infarcted area, TNF-α production, and neurological score to determine the therapeutic effects. The infarcted area was observed over a wide range in the untreated group, whereas shrinkage of the infarcted area was observed in rats subjected to intranasal administration of siTNF-α with PEG-PCL-Tat micelles. Moreover, TNF-α production and neurological score in rats treated by intranasal administration of siTNF-α with PEG-PCL-Tat micelles were significantly lower than those in untreated and naked siTNF-α-treated rats. These results indicate that nose-to-brain delivery of siTNF-α conjugated with PEG-PCL-Tat micelles alleviated the symptoms of cerebral ischemia-reperfusion injury. MDPI 2019-09-15 /pmc/articles/PMC6781507/ /pubmed/31540164 http://dx.doi.org/10.3390/pharmaceutics11090478 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kanazawa, Takanori
Kurano, Takumi
Ibaraki, Hisako
Takashima, Yuuki
Suzuki, Toyofumi
Seta, Yasuo
Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles
title Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles
title_full Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles
title_fullStr Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles
title_full_unstemmed Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles
title_short Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles
title_sort therapeutic effects in a transient middle cerebral artery occlusion rat model by nose-to-brain delivery of anti-tnf-alpha sirna with cell-penetrating peptide-modified polymer micelles
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781507/
https://www.ncbi.nlm.nih.gov/pubmed/31540164
http://dx.doi.org/10.3390/pharmaceutics11090478
work_keys_str_mv AT kanazawatakanori therapeuticeffectsinatransientmiddlecerebralarteryocclusionratmodelbynosetobraindeliveryofantitnfalphasirnawithcellpenetratingpeptidemodifiedpolymermicelles
AT kuranotakumi therapeuticeffectsinatransientmiddlecerebralarteryocclusionratmodelbynosetobraindeliveryofantitnfalphasirnawithcellpenetratingpeptidemodifiedpolymermicelles
AT ibarakihisako therapeuticeffectsinatransientmiddlecerebralarteryocclusionratmodelbynosetobraindeliveryofantitnfalphasirnawithcellpenetratingpeptidemodifiedpolymermicelles
AT takashimayuuki therapeuticeffectsinatransientmiddlecerebralarteryocclusionratmodelbynosetobraindeliveryofantitnfalphasirnawithcellpenetratingpeptidemodifiedpolymermicelles
AT suzukitoyofumi therapeuticeffectsinatransientmiddlecerebralarteryocclusionratmodelbynosetobraindeliveryofantitnfalphasirnawithcellpenetratingpeptidemodifiedpolymermicelles
AT setayasuo therapeuticeffectsinatransientmiddlecerebralarteryocclusionratmodelbynosetobraindeliveryofantitnfalphasirnawithcellpenetratingpeptidemodifiedpolymermicelles